Drug
Ins1033
Ins1033: highest development phase Phase 1, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| INS1033 NCT07765706 | Phase 1 |
Latest
No recent events.
Follow Ins1033 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.